242 related articles for article (PubMed ID: 27117950)
1. Stress Test of Contrast-Enhanced US with Phenylephrine in a Rabbit VX2 Liver Tumor Model: Differentiating Benign Periablational Enhancement from Residual Tumor after Radiofrequency Ablation.
Kan X; Zhang Y; Zheng C; Li L; Chen J; Wu Y; Guo T; Xiong B
J Vasc Interv Radiol; 2016 Jul; 27(7):1077-1085.e2. PubMed ID: 27117950
[TBL] [Abstract][Full Text] [Related]
2. VX2 carcinoma in rabbits after radiofrequency ablation: comparison of MR contrast agents for help in differentiating benign periablational enhancement from residual tumor.
Kim TJ; Moon WK; Cha JH; Goo JM; Lee KH; Kim KH; Lee JW; Han JG; Weinmann HJ; Chang KH
Radiology; 2005 Feb; 234(2):423-30. PubMed ID: 15591437
[TBL] [Abstract][Full Text] [Related]
3. Ablation of high intensity focused ultrasound combined with SonoVue on rabbit VX2 liver tumors: assessment with conventional gray-scale US, conventional color/power Doppler US, contrast-enhanced color Doppler US, and contrast-enhanced pulse-inversion harmonic US.
Luo W; Zhou X; He G; Li Q; Zheng X; Fan Z; Liu Q; Yu M; Han Z; Zhang J; Qian Y
Ann Surg Oncol; 2008 Oct; 15(10):2943-53. PubMed ID: 18612702
[TBL] [Abstract][Full Text] [Related]
4. Color Coded Perfusion Imaging with Contrast Enhanced Ultrasound (CEUS) for Post-Interventional Success Control Following Irreversible Electroporation (IRE) of Primary and Secondary Malignant Liver Lesions.
Rennert J; Wiesinger I; Schicho A; Wiggermann P; Stroszczynski C; Beyer LP; Jung EM
J Gastrointestin Liver Dis; 2019 Sep; 28(3):311-318. PubMed ID: 31517328
[TBL] [Abstract][Full Text] [Related]
5. Enhanced ablation of high intensity focused ultrasound with microbubbles: an experimental study on rabbit hepatic VX2 tumors.
He W; Wang W; Zhou P; Wang YX; Zhou P; Li RZ; Wang JS; Ahuja AT
Cardiovasc Intervent Radiol; 2011 Oct; 34(5):1050-7. PubMed ID: 21127863
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of benign periablational enhancement from residual tumor following radio-frequency ablation using contrast-enhanced ultrasonography in a rat subcutaneous colon cancer model.
Wu H; Patel RB; Zheng Y; Solorio L; Krupka TM; Ziats NP; Haaga JR; Exner AA
Ultrasound Med Biol; 2012 Mar; 38(3):443-53. PubMed ID: 22266229
[TBL] [Abstract][Full Text] [Related]
7. Contrast-enhanced US-guided radiofrequency ablation of hepatocellular carcinoma.
Rajesh S; Mukund A; Arora A; Jain D; Sarin SK
J Vasc Interv Radiol; 2013 Aug; 24(8):1235-40. PubMed ID: 23796857
[TBL] [Abstract][Full Text] [Related]
8. [Microbubbles enhanced HIFU ablation on rabbit hepatic VX2 tumors: detecting residual tumor with contrast-enhanced ultrasound and spiral CT].
He W; Wang W; Peng S
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2013 May; 42(3):337-44. PubMed ID: 23801624
[TBL] [Abstract][Full Text] [Related]
9. Ultrasound-guided percutaneous laser and ethanol ablation of rabbit VX2 liver tumors.
Zou X; Liu Q; Zhou X; He G; Yu M; Han Z; Meng X; Su H
Acta Radiol; 2013 Mar; 54(2):181-7. PubMed ID: 23482351
[TBL] [Abstract][Full Text] [Related]
10. Early Identification of Residual Tumors following Microwave Ablation Using Contrast-Enhanced Ultrasonography in a Rabbit VX2 Liver Cancer Model.
Yi H; Cai B; Ai X; Li K; Song P; Zhang W
Biomed Res Int; 2020; 2020():2462058. PubMed ID: 33029496
[TBL] [Abstract][Full Text] [Related]
11. Microwave coagulation/ablation in combination with sorafenib suppresses the overgrowth of residual tumor in VX2 liver tumor model.
Kong WT; Cai H; Tang Y; Zhang XL; Wang WP
Discov Med; 2016 Jun; 21(118):459-68. PubMed ID: 27448782
[TBL] [Abstract][Full Text] [Related]
12. Iodine quantification with dual-energy CT: phantom study and preliminary experience with VX2 residual tumour in rabbits after radiofrequency ablation.
Li Y; Shi G; Wang S; Wang S; Wu R
Br J Radiol; 2013 Sep; 86(1029):20130143. PubMed ID: 23884759
[TBL] [Abstract][Full Text] [Related]
13. Inflammation and cancer: inhibiting the progression of residual hepatic VX2 carcinoma by anti-inflammatory drug after incomplete radiofrequency ablation.
Jiang T; Zhang X; Ding J; Duan B; Lu S
Int J Clin Exp Pathol; 2015; 8(11):13945-56. PubMed ID: 26823706
[TBL] [Abstract][Full Text] [Related]
14. Is contrast-enhanced US alternative to spiral CT in the assessment of treatment outcome of radiofrequency ablation in hepatocellular carcinoma?
Ricci P; Cantisani V; Drudi F; Pagliara E; Bezzi M; Meloni F; Calliada F; Erturk SM; D'Andrea V; D'Ambrosio U; Passariello R
Ultraschall Med; 2009 Jun; 30(3):252-8. PubMed ID: 19280552
[TBL] [Abstract][Full Text] [Related]
15. The role of contrast-enhanced sonography for radiofrequency ablation of liver tumors.
Liu JB; Goldberg BB; Merton DA; Rawool NM; Needleman L; Forsberg F
J Ultrasound Med; 2001 May; 20(5):517-23. PubMed ID: 11345109
[TBL] [Abstract][Full Text] [Related]
16. Contrast-enhanced ultrasonography for the evaluation of liver fibrosis after biliary obstruction.
Shin HJ; Chang EY; Lee HS; Hong JH; Park G; Kim HG; Kim MJ; Lee MJ
World J Gastroenterol; 2015 Mar; 21(9):2614-21. PubMed ID: 25759528
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of quantitative contrast-enhanced ultrasound in hepatocellular carcinoma recurrence after ablation.
Gao Y; Zheng DY; Cui Z; Ma Y; Liu YZ; Zhang W
World J Gastroenterol; 2015 Sep; 21(36):10418-26. PubMed ID: 26420968
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous US-guided radiofrequency ablation with perfused needle applicators: improved survival with the VX2 tumor model in rabbits.
Hänsler J; Neureiter D; Wasserburger M; Janka R; Bernatik T; Schneider T; Müller W; Frieser M; Schaber S; Becker D; Hahn EG; Strobel D
Radiology; 2004 Jan; 230(1):169-74. PubMed ID: 14645878
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging.
Kim CK; Choi D; Lim HK; Kim SH; Lee WJ; Kim MJ; Lee JY; Jeon YH; Lee J; Lee SJ; Lim JH
Eur J Radiol; 2005 Oct; 56(1):66-73. PubMed ID: 15913940
[TBL] [Abstract][Full Text] [Related]
20. Radiofrequency ablation: effect of tumor- and organ-specific pharmacologic modulation of arterial and portal venous blood flow on coagulation diameter in an N1-S1 tumor model.
Wilkins LR; Wu H; Haaga JR; Exner A
J Vasc Interv Radiol; 2012 Jun; 23(6):826-32. PubMed ID: 22507596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
